Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies


Alzheimer’s disease and neurodegeneration: A brighter outlook?

Alzheimer’s disease (AD) is a devastating disease for the patient, their family and friends, and also their community and wider...
View Article

To hallucinate, or not to hallucinate – that is the question

The explosion of research interest, clinical development and funding of psychedelic therapeutics for disorders such as depression, PTSD and substance...
View Article

Optimal strategies for hit identification in drug discovery

What’s the optimal Hit ID approach to enable success? Here, we take a look at knowledge-based hit generation, HTS, big...
View Article